• Explore /
  • Poster
  • / Identification of markers for tumor- and immune-derived extracellular vesicles (EVs) in preclinical models.

Identification of markers for tumor- and immune-derived extracellular vesicles (EVs) in preclinical models.

Abstract Poster

Authors

null

Dove-Anna Johnson

NIH, Bethesda, MD

Dove-Anna Johnson , Michelle Pleet , Joshua Aden Welsh , Sean Cook , Jason Savage , Nooshin Mirza Nasiri , Kevin A. Camphausen , Kenneth D. Aldape , James L. Gulley , Beverly A Mock , Jay A. Berzofsky , Steve Jacobson , Jennifer C Jones

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Circulating Biomarkers

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3046)

DOI

10.1200/JCO.2022.40.16_suppl.3046

Abstract #

3046

Poster Bd #

38

Abstract Disclosures

Similar Posters

First Author: Ravi Kumar Paluri

First Author: Ben McCormick

First Author: Moh'd M. Khushman

First Author: Bahar Saberzadeh Ardestani